<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Patient-Focused Drug Development: Guidance 1-Collecting Comprehensive and Representative Input; Public Workshop; Request for Comments</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Patient-Focused Drug Development: Guidance 1-Collecting Comprehensive and Representative Input; Public Workshop; Request for Comments</h1>
    <p class="timestamp">Published: 2017-10-27 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing a public workshop to convene a discussion on methodological approaches that a person seeking to collect patient experience data for submission to FDA to inform regulatory decision making may use. The methods and approaches would be considered relevant and objective, and ensure that collected data are accurate and representative of the intended population, including methods to collect meaningful patient input throughout the drug development pro...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2017-23437</p>
    <p><strong>Publication Date:</strong> 2017-10-27</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2017/10/27/2017-23437/patient-focused-drug-development-guidance-1-collecting-comprehensive-and-representative-input-public">https://www.federalregister.gov/documents/2017/10/27/2017-23437/patient-focused-drug-development-guidance-1-collecting-comprehensive-and-representative-input-public</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2017-23437</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
